| Name | Title | Contact Details |
|---|
CRI Worldwide is a Clementon, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cary HealthCare L L C is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Small Bone Innovations, LLC (Main) Corp HQ is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Small Bone Innovations, LLC (Main) Corp HQ is based in New York, NY. You can find more information on Small Bone Innovations, LLC (Main) Corp HQ at www.totalsmallbone.com
Eskaton is a nonprofit senior services provider serving Northern California`s older adults for over 50 years. Through innovative approaches to health, housing and social services, Eskaton is Transforming the Aging Experience by offering life-enriching experiences and creating a culture of purposeful living. Well-being is the very center of our philosophy, and we express our belief that Age is Beautiful by celebrating the lives of older adults throughout the Eskaton family. Certified in 2019 as “A Great Place to Work” by Fortune Magazine, Eskaton genuinely cares about the financial security, health and well-being of their staff members. In addition to competitive pay and comprehensive benefits that include a company-funded retirement program, Eskaton employees appreciate knowing their work makes a real difference—both in the community, and in the lives they touch. (129/744) Employment opportunities at Eskaton our wide-ranging, including (but not limited to) the following: • Administration • Nursing • Care-Giving • Maintenance • Dining Services • Housekeeping • Security
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.